Early clinical trial data from a Covid-19 vaccine that is among those currently in late-stage testing have shown favorable responses among participants in terms of antibody and immune cell responses.…

Roche has launched a Phase III study in collaboration with Gilead to evaluate the safety and efficacy of Actemra/RoActemra (tocilizumab) in combination with remdesivir in hospitalised patients with severe COVID-19…

The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation) The high specificity of the test is crucial to determine reliably if a…